Migraine

Majority of patients experienced relief from migraine pain, consistent with findings from first pivotal Phase III study.

The drug met all 23 primary endpoints in its phase III trial and is expected to be submitted to the FDA by year's end.

Over a 12-month period, the drug showed a statistically significant reduction in the number of monthly migraine headache days.

Subcutaneous monoclonal antibodies could change the stagnant scope of migraine treatment.

On behalf of Pernix Therapeutics, Dr. George Nissan (Headache Specialist, North Texas Institute of Neurology and Headache) discusses common migraine triggers and everyday tweaks to help prevent them.

A statistically significant proportion of patients were migraine-free 2 hours after taking lasmiditan versus placebo.

Erenumab reduced the number of migraine-affected days per month in phase 2 and 3 studies of more than 2600 patients.

Eptinezumab for frequent episodic migraine (EM) met primary and key secondary endpoints in the PROMISE 1 phase 3 trial.

The anti-CGRP monoclonal antibody showed long-term efficacy versus placebo in migraine pain impact.

The monoclonal antibody will seek FDA approval this year.

Teva says fremanezumab showed clinically and statistically significant improvements in all endpoints.

Fremanezumab reduced chronic migraine headache day rates.

Eli Lilly drug reduces migraines by 4 to 5 days per month.

Study results coincide with FDA's recent decision on a stimulation device.

Those treated experienced an average decrease of 2.9 monthly migraine days.

"This is disease-specific, mechanism-based treatment," Amaal Starling enthuses.

Previous studies link vagus nerve stimulation to pain relief for various conditions.

Qudexy XR Extended-Release Capsules for migraine headache gets FDA approval.

Patients with more severe migraine had even better results.

Study results on the link between vitamin D and headache have a history of being ambiguous, but new research found more conclusive findings.

For individuals battling migraines, a morning cup of coffee or extra glass of wine can act as devastating headache triggers. Rather than excess caffeine, the true migraine trigger culprits are nitrites and monosodium glutamate (MSG).

Do you suffer from migraines? Cluster headaches? Tension headaches? Other kinds of headaches? All of them are related to a thyroid disorder, according to new research from the University of Cincinnati (UC).

Despite the availability of several treatment options, many people with migraine aren’t satisfied with their outcomes, according to the national Migraine in America 2016 survey created by Health Union.

Harvard researchers find that pure green light did not exacerbate pain in migraine sufferers, and may even reduce it by as much as 20%. The discovery could lead to innovations that make life much easier for those with frequent migraines.